ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CEL Celadon Pharmaceuticals Plc

100.00
2.00 (2.04%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 2.04% 100.00 98.00 105.00 101.50 98.00 98.00 73,885 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 24k -17.01M -0.2722 -3.73 63.41M
Celadon Pharmaceuticals Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 98p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 77.50p to 180.00p.

Celadon Pharmaceuticals currently has 62,469,773 shares in issue. The market capitalisation of Celadon Pharmaceuticals is £63.41 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.73.

Celadon Pharmaceuticals Share Discussion Threads

Showing 6301 to 6325 of 6825 messages
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older
DateSubjectAuthorDiscuss
04/3/2009
15:22
didn't that happen the other day, but up a penny instead !!!!!!!
dpeach
03/3/2009
08:21
BG good point, here's Bionostics web



Bionostics has worked with our partners in the in-vitro diagnostics industry for more than 26 years providing quality solutions to their critical needs. More recently, we have developed a variety of calibration verification and linearity products as well as point of care controls for in-vitro diagnostic uses. Bionostics has built a reputation for quality, integrity and efficiency in all aspects of our operations. We are Located 50 miles west of Boston in a modern plant geared to the needs of the Life Sciences industry.

wow a Chicago - Boston - Newark (New York) triangle could be happening here...
in-vitro for 26 years !!! hmmm

dpeach
02/3/2009
19:53
Has anyone spoken to Christopher Mills recently about his intentions wrt NAV's recent stake-building? He bought Bionostics (similarly sized, pharma servicing, N/E US based company) in March 2008. I guess there potentially could be major sysnergies by combining the two companies.
brummy_git
02/3/2009
16:38
see North Atlantic now on 16.4% as of the 26th Feb, seem to be happy to continue soaking up any lose stock.
dpeach
02/3/2009
13:53
V - 18500 sold today so far, 1000 bought @ 13:48 and price holds, imo buyer still in the background...hmmmm
dpeach
02/3/2009
11:27
Just need to tell someone: Look at the state of the market! Terrible! And then look at Celsis. Amazingly good!
verger
02/3/2009
09:37
got an email off JLC last friday, last line 'I am now very focused on securing an optimal year end for us so please forgive my short response'
I can live with 7 lines for an optimal year end...

dpeach
27/2/2009
09:43
Also, pre close trading update in March, historically Celsis stronger in 3 + 4 quarters, so that could bring some interesting info on IVT, etc progress.
dpeach
26/2/2009
17:15
imho JLC probably saw this coming (as Cel usually a shorters target on results + short selling had previously 'aided' move from £2+ to 140p) so orchestrated timing of North Atlantic buy in could certainly have helped. Boad iyo do you mean maket manipulation by shorters or institutional buying of added smaller amounts to go below the radar?
dpeach
26/2/2009
17:04
Could be.
Incidentally, 3 pairs of deals yesterday (and one pair today) look like roll-overs, in fact rolled over shorts seeing as the earlier of each pair is at the higher price. It smells a bit like an attempt at price manipulation which appears not to have worked so far. See what you make of it, dp.

boadicea
26/2/2009
15:51
Boad re. post 583 - looks like a background buyer is happy to encourage out the PI's offering a good bid price for their shares. Previously i've always been offered 10% plus off the bid price to sell a block of shares, today was offered 3% off so imho still accumulating
dpeach
26/2/2009
13:44
say was due to the 5400 shares sold at 13:19 via plus for 176.96...

sorry forgot link

dpeach
26/2/2009
13:40
W1 probably so, dips down though
dpeach
26/2/2009
12:57
Thanks dp, so probably from a week or so ago.
wywcu1
26/2/2009
12:50
wywcu1, i would say yes (due to the interest in 80,000 of my shares at 172.25p at 11:30am today, didn't sell) or a swap between institutions, certainly seems to be a buyer still in the background
dpeach
26/2/2009
12:32
What on earth is going on now? Are these possibly delayed buys?
wywcu1
26/2/2009
10:47
rel, i was going to say lol, but obviously very serious subject which they should consider, anyone found JLC showing on american t.v ?
dpeach
26/2/2009
10:16
dpeach

Perhaps after this event Novartis will look to rapid testing!!!

relwood
26/2/2009
09:13
steady buys @ 180 so far today, hopefully maintain above 170p line.. see in time
dpeach
26/2/2009
08:37
relwood, doesn't appear to be one of Celsis customers / partners
dpeach
26/2/2009
08:32
Does Celsis work with Novartis?
relwood
26/2/2009
08:23
wow selftrade offering at 180, bid of 177.25, tight spread and high bid..background buying again ???
dpeach
25/2/2009
14:04
Flow, would say that Celsis is one of the most illiquid stocks i have dealt it generally is held by institutions (growing % all the time) or by many long term PI's (personally have been in (and sold, re bought,etc) for the last 8 years).
Hence why buys / or sales of small blocks like the Robbie Burns crew tend to affect the price more significantly.

dpeach
25/2/2009
11:32
Stock must be pretty illiquid for a few PI's to drop the price in order for the big boys to buy in!
A good technical clue will be whether the price remains inside the current up-channel which began last October.
Flow

go with the flow
25/2/2009
11:17
uppola, next news should be mid / end march i think (going on previous years)
dpeach
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older

Your Recent History

Delayed Upgrade Clock